NCT02942810View on ClinicalTrials.gov

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

October 25, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions

Renal Impairment

Interventions

DRUG

WCK 5222

IV infusion over a period of 60 minutes

Trial Locations (1)

33136

University of Miami,Division of Clinical Pharmacology, Miami

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Clinartis

INDUSTRY

lead

Wockhardt

INDUSTRY